| abstract |
Disclosed herein are methods and devices for determining risk of, and treatment of, preeclampsia. Methods and devices employ polypeptide biomarkers, such as those provided in Table 1, Table 3, and Table 4. Further provided are panels comprising a plurality of polypeptide biomarkers useful for predicting risk of preeclampsia. |